SCHEMBL27909327

SCHEMBL27909327

Cc1ccc(N)c(N2CCC(OC(=O)NC(C)(C)C)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 2/20 0.44
MAPT P10636 5/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SCN1A P35498 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
GPR119 Q8TDV5 2/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
GAA P10253 2/20 0.36
POLB P06746 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27909309 0.86 LMNA (0.38) MAPTALDH1A1NPC1HPGDRAB9A
SCHEMBL27892293 0.84 NPC1 (0.47) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL27790954 0.84 GAA (0.51) MAPTALDH1A1KDM4ENPC1HPGD
SCHEMBL4443945 0.79 CKS1B (0.47) LGMNGPR119HDAC1HDAC2
SCHEMBL27666702 0.78 GFER (0.44) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL28558686 0.77 HRH3 (0.40) GPR119GAA
SCHEMBL16001294 0.77 LGMN (0.58) LGMNMAPTALDH1A1KDM4ENPC1
SCHEMBL27781993 0.75 ALOX15 (0.46) NPC1HPGDRAB9AHDAC1HDAC2
SCHEMBL26121646 0.74 HPGD (0.41) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL27988992 0.74 NOTUM (0.46) MAPTALDH1A1KDM4ENPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102947275-A Piperidinyl-substituted 1, 3-dihydro-benzimidazol-2-ylideneamine derivatives NOVARTIS AG 2013-02-27 CN disclosed